The Global Fund is trying to raise $15 billion to cover its programs from 2014 to 2016. The fund supports HIV therapy for more than 5 million people, as well as treatments for tuberculosis and malaria, and the distribution of insecticide-treated bed nets.
Also Monday, billionaire Bill Gates said he planned to nearly double his foundation's contribution to this next round of the Global Fund, to $500 million. Gates had already pledged $300 million, but told a small group of reporters at the National Institutes of Health that he would match an additional $200 million from private sources in an effort to draw in new donors.
Gates donned a biohazard suit and respirator for a close-up look at how NIH scientists are hunting new therapies for increasingly drug-resistant tuberculosis. He emerged from the laboratory energized about promising candidates but with a sober message for policymakers: Defeating global killers like TB and AIDS requires adequate funding of both the delivery of today's treatments and the research required for better ones.
"We're deeply disappointed" in cuts to the NIH's budget, Gates said.
Earlier this year, NIH lost $1.5 billion of its $31 billion budget to automatic spending cuts known as the sequester, after years of budgets that didn't keep up with inflation. NIH is scheduled to lose another $600 million from a second round of sequester cuts set to take effect next month. That in turn limits how much the NIH can devote to different diseases.
"Investing in research has huge paybacks," Gates said.